Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Inhibikase Therapeutics (IKT): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
9 analysts
Options Flow (P/C)
—
Avg Consensus PT
$5
+174.4%
Highest Price Target
$8
+344.4%
Lowest Price Target
$2
-16.7%
Short Interest
21.7%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Chardan Capital | Andreas Argyrides— | -16.7% | $2 | Initiate | Neutral |
| Jun 10, 2026 | Oppenheimer | —— | +177.8% | $5 | Initiate | Outperform |